News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,790 Results
Type
Article (44339)
Company Profile (276)
Press Release (675175)
Section
Business (208824)
Career Advice (2101)
Deals (36064)
Drug Delivery (104)
Drug Development (82642)
Employer Resources (174)
FDA (16822)
Job Trends (15194)
News (353299)
Policy (33579)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2723)
Accelerated approval (5)
Adcomms (22)
Allergies (83)
Alliances (51215)
ALS (89)
Alzheimer's disease (1400)
Antibody-drug conjugate (ADC) (114)
Approvals (16816)
Artificial intelligence (248)
Autoimmune disease (20)
Automation (14)
Bankruptcy (364)
Best Places to Work (11905)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (199)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (258)
Cancer (2067)
Cardiovascular disease (183)
Career advice (1750)
Career pathing (30)
CAR-T (146)
Cell therapy (410)
Cervical cancer (20)
Clinical research (66876)
Collaboration (799)
Compensation (488)
Complete response letters (21)
COVID-19 (2664)
CRISPR (38)
C-suite (218)
Cystic fibrosis (100)
Data (2017)
Decentralized trials (2)
Denatured (17)
Depression (41)
Diabetes (258)
Diagnostics (6505)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (115)
Drug pricing (106)
Drug shortages (26)
Duchenne muscular dystrophy (86)
Earnings (87289)
Editorial (32)
Employer branding (21)
Employer resources (148)
Events (114741)
Executive appointments (662)
FDA (17961)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (720)
Gene editing (104)
Generative AI (22)
Gene therapy (291)
GLP-1 (725)
Government (4545)
Grass and pollen (4)
Guidances (49)
Healthcare (19488)
Huntington's disease (22)
IgA nephropathy (26)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2797)
Inflammatory bowel disease (133)
Inflation Reduction Act (9)
Influenza (48)
Intellectual property (87)
Interviews (323)
IPO (16674)
IRA (42)
Job creations (3711)
Job search strategy (1489)
Kidney cancer (10)
Labor market (34)
Layoffs (462)
Leadership (17)
Legal (8101)
Liver cancer (72)
Lung cancer (302)
Lymphoma (138)
Machine learning (4)
Management (59)
Manufacturing (275)
MASH (62)
Medical device (13924)
Medtech (13929)
Mergers & acquisitions (19870)
Metabolic disorders (659)
Multiple sclerosis (76)
NASH (17)
Neurodegenerative disease (87)
Neuropsychiatric disorders (24)
Neuroscience (1909)
NextGen: Class of 2025 (6792)
Non-profit (4615)
Northern California (2483)
Now hiring (37)
Obesity (356)
Opinion (212)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (78)
Parkinson's disease (143)
Partnered (20)
Patents (206)
Patient recruitment (99)
Peanut (48)
People (58391)
Pharmaceutical (66)
Pharmacy benefit managers (20)
Phase I (20865)
Phase II (29430)
Phase III (21927)
Pipeline (1080)
Podcasts (52)
Policy (117)
Postmarket research (2631)
Preclinical (8914)
Press Release (69)
Prostate cancer (94)
Psychedelics (31)
Radiopharmaceuticals (247)
Rare diseases (372)
Real estate (6064)
Recruiting (66)
Regulatory (22934)
Reports (46)
Research institute (2455)
Resumes & cover letters (366)
Rett syndrome (4)
RNA editing (4)
RSV (40)
Schizophrenia (68)
Series A (126)
Series B (84)
Service/supplier (12)
Sickle cell disease (51)
Southern California (2146)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (28)
Startups (3702)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (11)
The Weekly (33)
United States (21715)
Vaccines (689)
Venture capitalists (37)
Webinars (12)
Weight loss (240)
Women's health (33)
Worklife (15)
Date
Today (45)
Last 7 days (628)
Last 30 days (2471)
Last 365 days (33905)
2025 (8475)
2024 (35868)
2023 (40861)
2022 (52033)
2021 (56684)
2020 (55269)
2019 (48054)
2018 (36196)
2017 (33192)
2016 (32701)
2015 (38834)
2014 (32598)
2013 (27793)
2012 (29965)
2011 (30592)
2010 (28740)
Location
Africa (763)
Alabama (49)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (39552)
Australia (6478)
California (5655)
Canada (1896)
China (483)
Colorado (253)
Connecticut (270)
Delaware (128)
Europe (86253)
Florida (844)
Georgia (202)
Idaho (61)
Illinois (510)
India (25)
Indiana (293)
Iowa (9)
Japan (145)
Kansas (103)
Kentucky (23)
Louisiana (9)
Maine (61)
Maryland (852)
Massachusetts (4289)
Michigan (209)
Minnesota (383)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (25)
Nevada (56)
New Hampshire (65)
New Jersey (1610)
New Mexico (29)
New York (1629)
North Carolina (957)
North Dakota (7)
Northern California (2483)
Ohio (195)
Oklahoma (14)
Oregon (35)
Pennsylvania (1272)
Puerto Rico (9)
Rhode Island (27)
South America (1146)
South Carolina (18)
South Dakota (1)
Southern California (2146)
Tennessee (96)
Texas (839)
Utah (166)
Virginia (135)
Washington D.C. (58)
Washington State (533)
West Virginia (3)
Wisconsin (49)
719,790 Results for "cardiovascular systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in development to date” in the competitive Lp(a) space, where drugs are designed to lower the risk of cardiovascular events such as heart attack and stroke.
March 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Atherosclerotic Cardiovascular Disease Market Size to Reach USD 30.6 Billion by 2035, Impelled by Advancements in Novel Drug Therapies
Atherosclerotic Cardiovascular Disease Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Press Releases
Myant Acquires mmHg Inc. To Enhance Precision Medicine for Cardiovascular Care
January 6, 2025
·
4 min read
Press Releases
Semaglutide 2.4 mg reduces burden of total cardiovascular events in people with established cardiovascular disease and overweight or obesity
March 31, 2025
·
9 min read
Policy
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System
Terumo Cardiovascular, a global leader in cardiovascular surgery technologies, announced that the U.S. Food and Drug Administration has granted 510 clearance for the CDI OneView Monitoring System.
May 28, 2024
·
3 min read
Cardiovascular disease
Deep Dive: Cardiovascular Disease Back in the Spotlight
In this deep dive,
BioSpace
explores the diverse therapeutic modalities now in development, as well as the opportunities and battles for market dominance in this emerging space.
March 10, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
April 1, 2025
·
11 min read
Press Releases
Prolocor(R) Announces Publication in Circulation: Cardiovascular Interventions. Results Demonstrate That the Prolocor pFCG(TM) Test Predicts Risk of Subsequent Cardiovascular Events Regardless of Treatment Strategy (Percutaneous Coronary Intervention or Medical Management Alone)
March 31, 2025
·
4 min read
Press Releases
Vascular Dementia Market Size to Reach USD 3.5 Billion by 2035, Impelled by Increasing Prevalence of Cardiovascular Diseases
February 14, 2025
·
7 min read
Press Releases
SCORE analysis of semaglutide 2.4 mg demonstrated reduction in cardiovascular events in a real-world setting
March 31, 2025
·
6 min read
1 of 71,979
Next
